Literature DB >> 9126262

Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences.

Z Z Xu1, A Hyatt, D B Boyle, G W Both.   

Abstract

An ovine adenovirus which may be the prototype for a new group of adenoviruses has been engineered as a gene transfer vector. One recombinant containing a 0.95-kb insertion expressed a sheep parasite antigen from the ovine adenovirus major late promoter and tripartite leader sequences. It was shown that insertions of at least 4.3 kb were tolerated at either one of two sites in the genome without the introduction of a compensating deletion. The unique structure of this viral genome was further emphasized by the discovery that four open reading frames at the right hand end show significant identity to each other but not to other sequences in the databases. Two other unrelated open reading frames were also present. RT-PCR analysis identified two transcripts in this region which were derived from a promoter which was located very close to, or within the ITR sequence. Splicing removed all but the first and last of the ORFs from these RNAs, suggesting that some sequences might be nonessential for replication in vitro. A approximately 2-kb deletion, which removed or truncated the internal reading frames was introduced into the region without affecting virus viability. The carrying capacity of OAV recombinants should therefore be at least 6.3 kb. The relative packaging capacity of OAV (114%) therefore exceeds that of Ad5 (105%), although a comparison of virus particle sizes by electron microscopy showed that OAV was smaller than Ad5. These studies improve the potential utility of OAV as a gene transfer vector.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126262     DOI: 10.1006/viro.1997.8452

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.

Authors:  C Hofmann; P Löser; G Cichon; W Arnold; G W Both; M Strauss
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.

Authors:  E J Kremer; S Boutin; M Chillon; O Danos
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3.

Authors:  P S Reddy; N Idamakanti; A N Zakhartchouk; M K Baxi; J B Lee; C Pyne; L A Babiuk; S K Tikoo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Replication-defective bovine adenovirus type 3 as an expression vector.

Authors:  P S Reddy; N Idamakanti; Y Chen; T Whale; L A Babiuk; M Mehtali; S K Tikoo
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors.

Authors:  A I Michou; H Lehrmann; M Saltik; M Cotten
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein.

Authors:  Soumitra Roy; Gary P Kobinger; Jianping Lin; Joanita Figueredo; Roberto Calcedo; Darwyn Kobasa; James M Wilson
Journal:  Vaccine       Date:  2007-08-06       Impact factor: 3.641

Review 7.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

8.  Biology of ovine adenovirus infection of nonpermissive cells.

Authors:  Daniel Kümin; Christian Hofmann; Michael Rudolph; Gerald W Both; Peter Löser
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Construction, rescue, and characterization of vectors derived from ovine atadenovirus.

Authors:  Peter Löser; Christian Hofmann; Gerald W Both; Wolfgang Uckert; Moritz Hillgenberg
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.

Authors:  Alessandra Vitelli; Mary R Quirion; Chia-Yun Lo; Julia A Misplon; Agnieszka K Grabowska; Angiolo Pierantoni; Virginia Ammendola; Graeme E Price; Mark R Soboleski; Riccardo Cortese; Stefano Colloca; Alfredo Nicosia; Suzanne L Epstein
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.